Nasdaq-Listed Biotech Firm Eyenovia Invests $50 Million in Hyperliquid’s HYPE Token, Signals Major Crypto Push
Eyenovia, Inc., a Nasdaq-listed ophthalmic technology company, has announced a significant $50 million investment in Hyperliquid’s native cryptocurrency, HYPE. This move marks Eyenovia as the first publicly traded U.S. company to hold HYPE tokens in its treasury and to become a validator on the Hyperliquid blockchain network. The funding was ...
Read moreDetails
